Abstract
Purpose
The aim of this study was to compare the outcomes of in vitro fertilization (IVF) for couples where one or both partners were positive for the human immunodeficiency virus (HIV) to matched control couples.
Methods
A matched case–control retrospective study was performed. Data for 104 couples where the woman was HIV-positive; for 90 couples where the man was HIV-positive; and for 33 couples where both partners were HIV-positive were prospectively analyzed in comparison to matched controls treated in our center during the same period. The main outcomes were clinical pregnancy and live birth rates.
Results
For couples involving an HIV-positive man, clinical outcomes were comparable to controls and resulted in the birth of 18 healthy babies after 90 cycles. When the woman was affected, cycle cancelation, number of retrieved oocytes, and on-going clinical pregnancy rates per transfer were statistically reduced. Implantation rates were comparable to those of non-affected controls. Seven healthy babies for 104 cycles were obtained. For a couple in which both partners were HIV-positive, only one healthy birth occurred after 33 cycles. Pregnancy rates were systematically reduced though not significantly probably due to sample size.
Conclusions
Our data suggest that IVF outcomes were similar to controls when men were HIV-positive and remain acceptable when women were HIV-positive. IVF outcomes were severely reduced in our sero-concordant couples; however, many patients had severe HIV disease previously, and therefore, these results should be reassessed in patients treated early in their disease.
Similar content being viewed by others
References
UNAIDS Catalogage à la source (2013) Bibliothèque de l’OMS: Rapport mondial: Rapport ONUSIDA sur l’épidémie mondiale de sida 2013. «ONUSIDA/JC2502/1/F» http://www.unaids.org/en/resources/campaigns/globalreport/globalreport/
Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 33(4):144–152 (165)
Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372(9635):293–299. doi:10.1016/S0140-6736(08)61113-7
Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E, Oneta M, Pardi G (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340(8831):1317–1319
Sturt AS, Dokubo EK, Sint TT (2010) Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 3:CD008440. doi:10.1002/14651858.CD008440
Barnes A, Riche D, Mena L, Sison T, Barry L, Reddy R, Shwayder J, Parry J (2014) Efficacy and safety of intrauterine insemination and assisted reproductive technology in populations serodiscordant for human immunodeficiency virus: a systematic review and meta-analysis. Fertil Steril 102(2):424–434. doi:10.1016/j.fertnstert.2014.05.001 (Epub 2014 Jun 18. Review)
Ohl J, Partisani M (2007) The desire to become a parent when infected with human immunodeficiency virus, hepatitis C virus or hepatitis B virus [Article in French]. Gynecol Obstet Fertil 35(10):1035–1038 (Epub 2007 Sep)
Santulli P, Gayet V, Fauque P, Chopin N, Dulioust E, Wolf JP, Chapron C, de Ziegler D (2011) HIV-positive patients undertaking ART have longer infertility histories than age-matched control subjects. Fertil Steril 95(2):507–512. doi:10.1016/j.fertnstert.2010.09.018
Manigart Y, Rozenberg S, Barlow P, Gerard M, Bertrand E, Delvigne A (2006) ART outcome in HIV-infected patients. Hum Reprod 21(11):2935–2940 (Epub 2006 Aug 3)
Bertrand E, Zissis G, Marissens D, Gérard M, Rozenberg S, Barlow P, Delvigne A (2004) Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology. AIDS 18(5):823–825
Gilling-Smith C, Almeida P (2003) Practice and Policy Committee of the British Fertility Society. HIV, hepatitis B and hepatitis C and infertility: reducing risk. Hum Fertil Camb 6(3):106–112
Delvigne A, Kostyla K, Murillo D, Van Hoeck J, Rozenberg S (2009) Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. Int J Fertil Womens Med 48(1):25–31
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245. doi:10.1093/humupd/dmp048 (Epub 2009 Nov 24)
Vandamme AM, Fransen K, Debaisieux L, Marissens D, Sprecher S, Vaira D, Vandenbroucke AT, Verhofstede C (1995) Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods 51(2–3):305–316
Shaw-Jackson C, Bertrand E, Becker B, Colin J, Beaudoin-Chabot C, Rozenberg S, Autin C (2013) Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming. J Assist Reprod Genet 30(8):1035–1042. doi:10.1007/s10815-013-0037-7 (Epub 2013 Jul 10)
Gardner DK, Schoolcraft WB (1999) In vitro culture of human blastocyst. In: Jansen R, Mortimer D (eds) Towards reproductive certainty: infertility and genetics beyond. Parthernon Press, Carnforth, pp 378–388
Revised surveillance case definition for HIV infection-United States (2014) MMWR Recomm Rep 63(RR-03):1–10
Gout C, Rougier N, Oger P, Dorphin B, Kahn V, Jacquesson L, Ayel JP, Yazbeck C (2011) Assisted Reproductive Technologies in HIV patients: a comprehensive review of indications, techniques and results [Article in French]. Gynecol Obstet Fertil 39(12):704–708. doi:10.1016/j.gyobfe.2011.07.029 (Epub 2011 Aug 25)
Prisant N, Tubiana R, Lefebvre G, Lebray P, Marcelin AG, Thibault V, Rosenblum O, Bonmarchand M, Vauthier-Brouzes D, Golmard JL, Katlama C, Poirot C (2010) HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome. Fertil Steril 93(3):1020–1023. doi:10.1016/j.fertnstert.2009.07.1663 (Epub 2009 Sep 3)
Kashima K, Takakuwa K, Suzuki M, Makino M, Kaneko S, Kato S, Hanabusa H, Tanaka K (2009) Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: a comparison of the pregnancy rates in HIV-1-discordant couples and control couples. Jpn J Infect Dis 62(3):173–176
Guibert J, Merlet F, Le Dû A, Mandelbrot L, Leruez-Ville M, Costagliola D, Kunstmann J-M, De Almeida M, Heard I, Dulioust E, Rouzioux C, Sicard D, Salmon D, Zorn J-R, Jouannet P (2001) Prise en charge des couples séro-différents pour le VIH. Résultats du protocole NECO (ANRS 092) à Paris. Reprod Hum Horm 14:363–364
Marina S, Semprini AE, Marina F et al (2003) Results of 219 IVF-ICSI cycles in serodiscordant couples (seropositive men) to HIV-1. Hum Reprod 18(Suppl 1):xviii152
Mencaglia L, Falcone P, Lentini GM, Consigli S, Pisoni M, Lofiego V, Guidetti R, Piomboni P, De Leo V (2005) ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner. Hum Reprod 20(8):2242–2246
Sauer MV, Wang JG, Douglas NC, Nakhuda GS, Vardhana P, Jovanovic V, Guarnaccia MM (2009) Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 91(6):2455–2460. doi:10.1016/j.fertnstert.2008.04.013 (Epub 2008 Jun 13)
Savasi V, Ferrazzi E, Lanzani C, Oneta M, Parrilla B, Persico T (2007) Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Hum Reprod 22(3):772–777 (Epub 2006 Nov 15)
Veiga A, Coll O, Tur R, Busquets A, Barri PN (1999) Assisted reproductive technologies and HIV-1 serodiscordant couples. Prenat Neonat Med 4:356–361
Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, Vernazza P, Ohl J, Weigel M, Englert Y, Semprini AE (2007) CREAThE network. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 21(14):1909–1914
Sauer MV, Chang PL (2002) Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. Am J Obstet Gynecol 186(4):627–633
Nicopoullos JD, Almeida P, Vourliotis M, Goulding R, Gilling-Smith C (2010) A decade of sperm washing: clinical correlates of successful insemination outcome. Hum Reprod 25(8):1869–1876. doi:10.1093/humrep/deq134 (Epub 2010 Jun 9)
Sergerie M, Martinet S, Kiffer N, Teulé R, Pasquier C, Bujan L (2004) Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques [Article in French]. Gynecol Obstet Fertil. 32(10):841–849
Van Leeuwen E, Repping S, Prins JM, Reiss P, van der Veen F (2009) Assisted reproductive technologies to establish pregnancies in couples with an HIV-1-infected man. Neth J Med 67(8):322-7. Review
Coll O, Suy A, Figueras F, Vernaeve V, Martínez E, Mataró D, Durban M, Lonca M, Vidal R, Gatell JM (2006) Decreased pregnancy rate after in vitro fertilization in HIV-infected women receiving HAART. AIDS 20(1):121–123
Nurudeen SK, Grossman LC, Bourne L, Guarnaccia MM, Sauer MV, Douglas NC (2013) Reproductive outcomes of HIV seropositive women treated by assisted reproduction. J Womens Health (Larchmt) 22(3):243–249. doi:10.1089/jwh.2012.3855 (Epub 2013 Feb 25)
Terriou P, Auquier P, Chabert-Orsini V, Chinchole JM, Cravello L, Giorgetti C, Halfon P, Salzmann J, Roulier R (2005) Outcome of ICSI in HIV-1-infected women. Hum Reprod 20(10):2838–2843 (Epub 2005 Jun 24)
Martinet V, Manigart Y, Rozenberg S, Becker B, Gerard M, Delvigne A (2006) Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study. Hum Reprod 21(5):1212–1217 (Epub 2006 Jan 26)
Englert Y, Lesage B, Van Vooren JP, Liesnard C, Place I, Vannin AS, Emiliani S, Delbaere A (2004) Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update 10(2):149–62 (Review)
Ohl J, Partisani M, Demangeat C, Binder-Foucard F, Nisand I, Lang JM (2010) Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women. [Article in French]. Gynecol Obstet Fertil 38(5):313–317. doi:10.1016/j.gyobfe.2009.07.019 (Epub 2010 Apr 28)
Author information
Authors and Affiliations
Contributions
PV project development, data collection, data analysis, and manuscript writing/editing. YM: protocol and project development, data analysis, and manuscript editing. AD: protocol and project development, and manuscript editing. LA: statistical analysis and manuscript editing. DK: protocol and project development, data analysis, and manuscript editing. CSJ: data collection, data analysis, and manuscript writing/editing. SR: project development, data analysis, and manuscript writing/editing. CA: protocol and project development, and manuscript editing.
Corresponding author
Ethics declarations
Informed consent
Informed consent was obtained from all individual participants included in the study. In addition, for HIV-positive couples, a specific informed consent was signed.
Conflict of interest
The authors declare that they have no conflict of interest. No funding was received for this study.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Additional information
Pauline Vankerkem and Yannick Manigart shared first authorship.
Rights and permissions
About this article
Cite this article
Vankerkem, P., Manigart, Y., Delvigne, A. et al. In vitro fertilization when men, women, or both partners are positive for HIV: a case–control study. Arch Gynecol Obstet 295, 1493–1507 (2017). https://doi.org/10.1007/s00404-017-4374-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-017-4374-0